Regulatory
Pharma Faces More Cost and Effectiveness Comparisons
The latest organization to join the cost-effectiveness stampede is the National Comprehensive Cancer Network (NCCN), which recently announced that it would add a new “tool” to its widely used guidelines that advise oncologists on cancer treatment strategies. Jill Wechsler reports
...Read more |
 |
Regulatory
Will a French Reconnection Help Regulatory Convergence in Europe?
Fifty years after the first European Union drug regulation was adopted, it may seem odd to speak of Europe still edging towards convergence in this field. But, writes Reflector, this is still the case, and France's bid to regain its regulatory influence reveals how far Europe is from fully achieving it
...Read more |
Redefining what marketing means to pharma. Creating engagements with value and purpose. Realize your potential with integrated services from Intouch Solutions. Intouchsol.com/Genome
 Learn more
 |
Comment
Phage Response? Using the Killers' Weapons
After Ansis Helmanis asked in last week's Pharm Exec Direct why bacteriophages for human use are not commercially available in the US (“What's Holding Up a 100-Year-Old Super Bug Killer?”), Markus Matuschka de Greiffenclau, CEO of Lysando AG, responds: while we should not rule out phages, he says,we should not use them as bacteria killers
...Read more |
While the regulatory environment has been evolving over the past few years and conducting business under the Sunshine law has been challenging, submissions published during the course of 2013 and 2014 highlighted some best practices life sciences companies can use to develop a tactical roadmap to address aggregate spend needs. Learn more about these best practices in a new IMS Health white paper.
 Download Now |
Technology
Time for a Wearable Strategy
Analysts are saying that more than 4 million Apple Watches were sold in the Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung. This continued rise of wearable technology is thanks in particular to health and fitness applications. Peter Houston reports
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Global
China's Pharma Industry Resilient in the Face of Slowing Economy
The current economic slowdown notwithstanding, a new survey offers a very positive outlook for the pharma industry in China, with 92 percent of respondents believing their China sales will double over the next five years. Cameron Sharp reports
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
 |
 // Otonomy, Inc. (San Diego,CA) announced the appointment of Ted Schroeder to its board of directors// GenomOncology (Cleveland, OH) announced that Benjamin Salisbury, Ph.D., has joined the company as Vice President, New Products and Marketing.// Shire appointed Sara Mathew to its Board of Directors as a Non-Executive Director. // Matinas BioPharma (Bedminster NJ) announced that Raphael J. Mannino, Ph.D., has been appointed Senior Vice President and Chief Technology Officer.// |
|
|
